Precordior

The company's CE-marked Class IIa medical device app detects atrial fibrillation with high accuracy using smartphone sensors. Clinical studies have shown strong results in detecting heart failure and ongoing trials are validating additional indications such as aortic stenosis. The solution has been validated in peer-reviewed publications and multicenter studies.[1][4][5] Recent US market entry includes partnerships with JISEKI Health and academic collaborations with Stanford University and Mayo Clinic.[4] Detection of heart failure demonstrated high accuracy compared to existing clinical methods.[4] The company continues to expand its scientific evidence base.